Cargando…

Cerebrovascular Disease and Statins

Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular disease (ASCVD); accordingly, LDL-C lowering is associated with a decreased risk of progression of atherosclerotic plaques and development of complications. Currently, statin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beltrán Romero, Luis M., Vallejo-Vaz, Antonio J., Muñiz Grijalvo, Ovidio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674469/ https://www.ncbi.nlm.nih.gov/pubmed/34926626 http://dx.doi.org/10.3389/fcvm.2021.778740

Ejemplares similares

Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients
por: Miglinas, Marius, et al.
Publicado: (2020)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Cerebrovascular Events After Transcatheter Aortic Valve Implantation
por: Armijo, German, et al.
Publicado: (2018)

Carotid Artery Stiffness: Imaging Techniques and Impact on Cerebrovascular Disease
por: Baradaran, Hediyeh, et al.
Publicado: (2022)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Use of covered stents to treat complex cerebrovascular diseases: Expert consensus
por: Zhu, Yueqi, et al.
Publicado: (2022)

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Common Polymorphisms in the RGMa Promoter Are Associated With Cerebrovascular Atherosclerosis Burden in Chinese Han Patients With Acute Ischemic Cerebrovascular Accident
por: Hu, Qingzhe, et al.
Publicado: (2021)

Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
por: Singh, Satish, et al.
Publicado: (2020)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

New Imaging Signatures of Cardiac Alterations in Ischaemic Heart Disease and Cerebrovascular Disease Using CMR Radiomics
por: Rauseo, Elisa, et al.
Publicado: (2021)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications
por: Min, Xue, et al.
Publicado: (2021)

Exaggerated postural sway improves orthostatic cardiovascular and cerebrovascular control
por: Williams, Erin L., et al.
Publicado: (2023)

Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Non-linear Associations Between Visceral Adiposity Index and Cardiovascular and Cerebrovascular Diseases: Results From the NHANES (1999–2018)
por: Zhang, Yangchang, et al.
Publicado: (2022)

Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
por: Nawata, Kazumitsu
Publicado: (2023)

Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
por: Tudor, Kate, et al.
Publicado: (2020)

Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
por: Byrne, Paula, et al.
Publicado: (2018)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
por: Shah, Aditya, et al.
Publicado: (2022)

Statin associated adverse reactions in Latin America: a scoping review
por: Urina-Jassir, Manuel, et al.
Publicado: (2021)

Time trends in statin utilisation and coronary mortality in Western European countries
por: Vancheri, Federico, et al.
Publicado: (2016)

In situ assessment of statins’ effect on autophagic activity in zebrafish larvae cardiomyocytes
por: Zhang, Jie, et al.
Publicado: (2022)

Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants
por: Huang, Yi-Ming, et al.
Publicado: (2022)

Estimated pulse wave velocity is associated with all-cause and cardio-cerebrovascular disease mortality in stroke population: Results from NHANES (2003–2014)
por: Huang, Huoming, et al.
Publicado: (2023)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care
por: Herrett, Emily, et al.
Publicado: (2017)

The Cardiovascular and Cerebrovascular Health in North China From 2006 to 2011: Results From the KaiLuan Study
por: Yu, Yao, et al.
Publicado: (2021)

Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies
por: Zhang, Jun, et al.
Publicado: (2020)

Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
por: Du, Lixin, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

The effect of statins on average survival in randomised trials, an analysis of end point postponement
por: Kristensen, Malene Lopez, et al.
Publicado: (2015)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study
por: Kouhpeikar, Hamideh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4n8ijgjqod7fvku40pat1vcfa